siteFiles/LibraryPhotos/87C0D5E64FAAE750EA16A294A4CD21F1.jpg

Cynosure, Inc. to be Acquired by Hologic, Inc.

 

Fried Frank acted as counsel to Leerink Partners LLC as financial advisor to Cynosure, Inc. in its sale to Hologic, Inc. for US$66.00 per share in cash, an equity value of approximately US$1.65 billion. Cynosure has a broad portfolio of more than 20 products across major categories including non-invasive body contouring, hair removal, skin revitalization and women's health. Hologic is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products focused on women's health. The transaction provides Hologic with entry into the large, fast-growing medical aesthetics segment and is expected to accelerate Hologic's transformation into a higher-growth company.

The Fried Frank team included corporate partner Warren de Wied and corporate associate Elizabeth Kalenik.

majormatters-detail.inc